相关实验视频
Updated: Jun 10, 2025

10:19
A Murine Model of Group B Streptococcus Vaginal Colonization
Published on: November 16, 2016
14.3K
阴道中的乳酸菌产生抗炎β-卡博林化合物
Virginia J Glick1, Cecilia A Webber1, Lauren E Simmons1
1Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
Cell host & microbe
|October 18, 2024
概括
乳酸菌生产抗炎化合物,可以减少阴道炎症. 这些化合物,像perlolyrine一样,可能为细菌性阴道炎 (BV) 等炎症状况提供新的治疗方法.
科学领域:
- 微生物学 微生物学
- 免疫学 免疫学 免疫学
- 药理学 药理学是指药理学的学科.
背景情况:
- 阴道微生物组通常是乳酸菌占主导地位,对免疫恒温至关重要.
- 乳杆菌主导地位的丧失与诸如细菌性阴道炎 (BV) 等炎症状况相关.
- 除了Lactobacillus iners外,乳酸菌种与减少炎症和促炎细胞因子有关.
研究的目的:
- 为了识别由 Lactobacillus crispatus 生产的具有抗炎性质的化合物.
- 研究这些化合物对免疫信号通路的作用机制.
- 评估这些化合物的治疗潜力,以减少阴道炎症.
主要方法:
- 鉴定和描述来自Lactobacillus crispatus的β-carboline化合物.
- 测试以确定化合物对人体细胞中核因子 κB (NF-κB) 和干扰素 (IFN) 信号传递的影响.
- 在单细胞中评估I型干扰素受体 (IFNAR) 激活.
- 在生殖器疹的小鼠模型中局部注射perlolyrine以评估阴道炎症.
- 从健康个体和那些有BV的宫阴道洗 (CVL) 中的化合物水平的比较.
主要成果:
- 乳酸菌生产抗炎β-卡博林化合物. 乳酸菌生产抗炎β-卡博林化合物.
- 这些化合物抑制NF-κB和IFN信号通路.
- 在生殖器疹的小鼠模型中,珀洛利林显著降低了阴道炎症.
- 复合物在健康个体的CVL中比BV患者的CVL更为丰富.
结论:
- 阴道乳球菌产生β-卡博林化合物,这些化合物介导宿主免疫恒温.
- 这些发现突出了管理阴道炎症的潜在治疗策略.
- 准这些化合物可以为BV和相关的炎症条件提供新的治疗方法.
相关概念视频
Surface Membrane Barriers
1.1K
The skin and mucous membranes serve as the primary line of defense against pathogens by providing both physical and chemical protection. These barriers are essential in preventing the entry and establishment of microbes, thereby maintaining the integrity of the host.
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
1.1K
Bacterial Phylum Actinobacteria
Coryneform bacteria are gram-positive, aerobic, nonmotile rods that exhibit irregular, club-shaped, or V-shaped arrangements. Their V-shape results from snapping division, where the inner cell wall layer forms the cross-wall, while the outer layer remains intact until it ruptures on one side, causing the daughter cells to bend away.The primary genera are Corynebacterium and Arthrobacter. Corynebacterium includes diverse species, ranging from saprophytes to pathogens like Corynebacterium...
Bacterial Phylum Firmicutes
Firmicutes is a diverse phylum of Gram-positive bacteria characterized by a low GC content in their genomes. This phylum includes organisms with monoderm or diderm cell envelopes, highlighting a complex evolutionary history. Firmicutes comprises several major orders, including Lactobacillales, Clostridiales, and Bacillales, which exhibit remarkable diversity in their morphology, metabolism, and ecological roles.The order Lactobacillales includes lactic acid bacteria, which are fermentative...
Defense Mechanism Against Infection
6.5K
Natural flora, body system defenses, and inflammation are natural barriers of the body against infectious agents regardless of previous exposure. Normal floras of the human body refer to the microbial population that colonizes the skin and mucous membranes.
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
In addition, many body organ systems have unique defenses against infection. The skin is an intact, multilayered surface preventing invasion by microorganisms unless impaired. Mucous membranes lining the mouth, nose, and eyelids are barriers...
6.5K
Loss of Carboxy Group as CO2: Decarboxylation of Malonic Acid Derivatives
1.9K
Just like β-keto acids—which upon thermal decarboxylation form ketones—β-dicarboxylic acids undergo decarboxylation to generate monocarboxylic acids with the liberation of carbon dioxide.
1.9K
Drugs for Treatment of Constipation-Predominant IBS
139
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
139

